Hematology-oncology provider perspectives regarding lymphoma treatment and cardioprotective strategies in patients with lymphoma at high risk for heart failure

By sjmartinez • April 8, 2025

Anderson E, Choi Y, Buchsbaum RJ, Klein A, Ky B, Landsburg D, Durani U, Ruddy KJ, Yu AF, Leong D, Asnani A, Neilan TG, Ganatra S, Bloom M, Barac A, Yang EH, Deswal A, Cheng RK, Weiss M, Evens AM, Kahl B, Friedberg JW, Parsons SK, Upshaw JN. Hematology-oncology provider perspectives regarding lymphoma treatment and cardioprotective strategies in patients with lymphoma at high risk for heart failure. Leuk Lymphoma. 2025 Apr 8:1-10. doi: 10.1080/10428194.2025.2484367. Epub ahead of print. PMID: 40195874.

Tags: anthracycline, Cancer, Cancer survivorship, Cardiology/Epi, cardiomyopathy, cardioprotection, heart failure, Publications

Age and Procedural Timing for Asymptomatic Severe Aortic Stenosis: Analysis From the EARLY TAVR Trial

Goel K, Lindman BR, Schwartz A, Cohen DJ, Giustino G, Oldemeyer JB, Strote J, Babaliaros V, Devireddy CM, Fischbein MP, Fearon WF, Daniels D, Spies[...]

GPIHBP1 on oligodendrocytes binds lipoprotein lipase within the human brain

Liu M, Hung M, Kozlov E, Hung M, Colaço-Gaspar M, Roy S, Tu Y, Magaki SD, Williams CK, Andaloussi Mäe M, Johnson ECB, Siegel RW,[...]

Deep learning-based CT-derived vertebral bone mineral density and metformin therapy: a longitudinal study in the Multi-Ethnic Study of Atherosclerosis

Momtazmanesh S, Hathaway QA, Jannatdoust P, Ghotbi E, Bancks MP, Bluemke DA, Barr RG, Smith BM, Post WS, Budoff MJ, Lima JAC, Demehri S. Deep[...]